Adverse effects (at 12 months) · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life measures · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Glaucoma progression at 12 months, measured by additional visual field defects · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in IOP measured in mmHg 12 months postintervention · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
32 participants
Moderate
Mean number of antiglaucoma medications at 1‐year · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
32 participants
Moderate
Mean change in IOP measured in mmHg 12 months postintervention · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Gonioscopic findings (Anterior segment optical coherence tomography parameters) (at 6 months) · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
64 participants
GRADE not reported
Visual acuity · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (at 6 months) · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life measures · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Glaucoma progression at 12 months, measured by additional visual field defects · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in IOP measured in mmHg 12 months postintervention · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
63 participants
Low
Mean number of antiglaucoma medications at 1‐year · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
63 participants
Low
Gonioscopic findings · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean postoperative best‐corrected visual acuity · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
63 participants
Low
Adverse effects (up to 12 months) · participants with primary angle‐closure glaucoma
Phacoemulsification showed no clear difference in adverse effects (up to 12 months) compared with phacoemulsification plus trabeculectomy (low certainty).
1 finding from 1 review
RR 0.59 [0.34, 1.04]
63 participants
Low
Mean number of antiglaucoma medications at 1‐year · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Quality of life measures (at 12 months) · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Gonioscopic findings · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Visual acuity · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate